Semaglutide and Weight Loss Drugs May Increase Risk of Serious Eye Conditions
Novo Nordisk's weight loss drugs Ozempic and Wegovy are linked to rare cases of a serious eye condition called NAION, which can cause vision loss, prompting regulatory updates and further studies on their safety, especially concerning their use in diabetes and obesity treatment.